A Randomized, Double-Blind, Vehicle-Controlled, PArallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 07 Jun 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Jun 2018 Results of two identical studies (NCT02667236 and NCT02667275) assessing the safety and efficacy of hydrogen peroxide topical solution, 40%, published in the Journal of the American Academy of Dermatology
16 May 2018 According to an Aclaris Therapeutics media release, data will be presented at the International Investigative Dermatology (IID) 2018 Meeting.
08 Feb 2018 According to an Aclaris Therapeutics media release, data will be presented at the 2018 American Academy of Dermatology (AAD) Annual Meeting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com